T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRCL
1026
DELISTED
Stericycle Inc
SRCL
| $27.8M | 0.01% |
234,615
-733,220
| -76% | -$83.9M |
|
|
TXI
1027
DELISTED
TEXAS INDUSTRIES INC
TXI
| $27.6M | 0.01% |
299,040
-133,760
| -31% | -$11.7M |
|
1028
Paychex
PAYX
$42.8B
| $27.4M | 0.01% |
660,306
-11,700
| -2% | -$481K |
|
|
DF
1029
DELISTED
Dean Foods Company
DF
| $27.4M | 0.01% |
1,559,558
-6,572,642
| -81% | -$108M |
|
1030
Consolidated Edison
ED
$39.9B
| $27.2M | 0.01% |
471,364
-3,700
| -0.8% | -$207K |
|
1031
Preferred Bank
PFBC
$1.26B
| $27.1M | 0.01% |
1,145,353
+6,817
| +0.6% | +$158K |
|
1032
CTS Corp
CTS
$1.82B
| $27M | 0.01% |
1,445,060
-900
| -0.1% | -$16.6K |
|
1033
J.M. Smucker
SJM
$12.7B
| $27M | 0.01% |
253,014
+2,400
| +1% | +$241K |
|
1034
CF Industries
CF
$18.2B
| $26.8M | 0.01% |
557,380
-4,550
| -0.8% | -$223K |
|
|
MSCC
1035
DELISTED
Microsemi Corp
MSCC
| $26.8M | 0.01% |
1,001,720
+42,800
| +4% | +$1.07M |
|
|
X
1036
DELISTED
US Steel
X
| $26.8M | 0.01% |
1,028,355
+819,060
| +391% | +$20.9M |
|
1037
Valley National Bancorp
VLY
$8.25B
| $26.8M | 0.01% |
2,700,157
-46,831
| -2% | -$470K |
|
|
PTRY
1038
DELISTED
PANTRY INC (THE)
PTRY
| $26.6M | 0.01% |
1,642,290
-29,750
| -2% | -$463K |
|
|
SAVE
1039
DELISTED
Spirit Airlines, Inc.
SAVE
| $26.5M | 0.01% |
418,320
+51,153
| +14% | +$3.02M |
|
1040
Generac Holdings
GNRC
$13.1B
| $26.3M | 0.01% |
538,642
+146,818
| +37% | +$7.72M |
|
|
GTS
1041
DELISTED
Triple-S Management Corporation
GTS
| $26.1M | 0.01% |
1,532,387
-1,261
| -0.1% | -$20.3K |
|
|
PHX
1042
DELISTED
PHX Minerals
PHX
| $26.1M | 0.01% |
932,170
+3,300
| +0.4% | +$83.3K |
|
1043
Gentex
GNTX
$4.93B
| $26M | 0.01% |
1,788,616
+6,516
| +0.4% | +$95.1K |
|
|
PIKE
1044
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
| $25.9M | 0.01% |
2,887,916
+103,856
| +4% | +$970K |
|
|
CAA
1045
DELISTED
CalAtlantic Group, Inc.
CAA
| $25.8M | 0.01% |
601,098
-2,360
| -0.4% | -$95.8K |
|
1046
Hartford Financial Services
HIG
$37.7B
| $25.8M | 0.01% |
719,609
+31,500
| +5% | +$1.11M |
|
1047
Ciena
CIEN
$61.2B
| $25.5M | 0.01% |
1,176,305
+3,100
| +0.3% | +$63.7K |
|
1048
Main Street Capital
MAIN
$5.47B
| $25.3M | 0.01% |
768,559
+571,719
| +290% | +$18M |
|
1049
TechnipFMC
FTI
$29.5B
| $25.2M | 0.01% |
555,365
-1,925,968
| -78% | -$81.6M |
|
1050
Ribbon Communications
RBBN
$372M
| $25.2M | 0.01% |
1,403,258
+7,446
| +0.5% | +$126K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.